The incidence and risk factors of thrombosis and the need for thromboprophylaxis in lymphoma and leukemia patients: A 9-year single-center experience.

Abdulkerim YıldızMurat AlbayrakÇiğdem PalaHacer Berna Afacan Öztürk Senem MaralOsman ŞahinPınar Cömert

Published in: Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners (2019)

Acute leukemia patients with any comorbidity and lymphoma patients with higher lactate dehydrogenase and beta-2-microglobulin are at high risk of developing thromboembolic complications. The prophylactic use of anticoagulant should be considered for those patients especially in the first 6 months.

Keyphrases

end stage renal disease
ejection fraction
newly diagnosed
chronic kidney disease
peritoneal dialysis
venous thromboembolism
pulmonary embolism
acute myeloid leukemia
risk factors
patient reported outcomes